# Filing Detail

Form 8-K - Current report:
SEC Accession No. 0001178913-23-000147
Filing Date
2023-01-11
Accepted
2023-01-11 16:01:24
Documents
49
Period of Report
2023-01-11
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | 8-K | form8k.htm iXBRL | 8-K | 33593
2 | EXHIBIT 99.1 | exhibit_99-1.htm | EX-99.1 | 31320
7 |  | exhibit_99-1slide1.jpg | GRAPHIC | 68424
8 |  | exhibit_99-1slide2.jpg | GRAPHIC | 352206
9 |  | exhibit_99-1slide3.jpg | GRAPHIC | 126809
10 |  | exhibit_99-1slide4.jpg | GRAPHIC | 141425
11 |  | exhibit_99-1slide5.jpg | GRAPHIC | 120871
12 |  | exhibit_99-1slide6.jpg | GRAPHIC | 97668
13 |  | exhibit_99-1slide7.jpg | GRAPHIC | 114655
14 |  | exhibit_99-1slide8.jpg | GRAPHIC | 123851
15 |  | exhibit_99-1slide9.jpg | GRAPHIC | 132191
16 |  | exhibit_99-1slide10.jpg | GRAPHIC | 146785
17 |  | exhibit_99-1slide11.jpg | GRAPHIC | 135615
18 |  | exhibit_99-1slide12.jpg | GRAPHIC | 173932
19 |  | exhibit_99-1slide13.jpg | GRAPHIC | 140355
20 |  | exhibit_99-1slide14.jpg | GRAPHIC | 166548
21 |  | exhibit_99-1slide15.jpg | GRAPHIC | 133508
22 |  | exhibit_99-1slide16.jpg | GRAPHIC | 155777
23 |  | exhibit_99-1slide17.jpg | GRAPHIC | 84784
24 |  | exhibit_99-1slide18.jpg | GRAPHIC | 156712
25 |  | exhibit_99-1slide19.jpg | GRAPHIC | 147741
26 |  | exhibit_99-1slide20.jpg | GRAPHIC | 174421
27 |  | exhibit_99-1slide21.jpg | GRAPHIC | 139593
28 |  | exhibit_99-1slide22.jpg | GRAPHIC | 148094
29 |  | exhibit_99-1slide23.jpg | GRAPHIC | 152883
30 |  | exhibit_99-1slide24.jpg | GRAPHIC | 168063
31 |  | exhibit_99-1slide25.jpg | GRAPHIC | 138682
32 |  | exhibit_99-1slide26.jpg | GRAPHIC | 154844
33 |  | exhibit_99-1slide27.jpg | GRAPHIC | 183603
34 |  | exhibit_99-1slide28.jpg | GRAPHIC | 164920
35 |  | exhibit_99-1slide29.jpg | GRAPHIC | 156799
36 |  | exhibit_99-1slide30.jpg | GRAPHIC | 145004
37 |  | exhibit_99-1slide31.jpg | GRAPHIC | 137216
38 |  | exhibit_99-1slide32.jpg | GRAPHIC | 158770
39 |  | exhibit_99-1slide33.jpg | GRAPHIC | 204696
40 |  | exhibit_99-1slide34.jpg | GRAPHIC | 126916
41 |  | exhibit_99-1slide35.jpg | GRAPHIC | 31318
| Complete submission text file | 0001178913-23-000147.txt |  | 7283472

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
3 | XBRL TAXONOMY EXTENSION SCHEMA | cmmb-20230111.xsd | EX-101.SCH | 4644
4 | XBRL TAXONOMY EXTENSION DEFINITION LINKBASE | cmmb-20230111_def.xml | EX-101.DEF | 18314
5 | XBRL TAXONOMY EXTENSION LABEL LINKBASE | cmmb-20230111_lab.xml | EX-101.LAB | 28540
6 | XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE | cmmb-20230111_pre.xml | EX-101.PRE | 20556
43 | EXTRACTED XBRL INSTANCE DOCUMENT | form8k_htm.xml | XML | 6617

Mailing Address KIRYAT ATIDIM, BUILDING 7 TEL AVIV L3 6158002
Business Address KIRYAT ATIDIM, BUILDING 7 TEL AVIV L3 6158002 972-77-331-0156
Chemomab Therapeutics Ltd. (Filer) CIK: 0001534248 (see all company filings)

EIN.: 813676773 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38807 | Film No.: 23523596
SIC: 2834 Pharmaceutical Preparations